COMP <GO>
PDSB vs CNTN // EV/EBITDA & P/E VALUATION
PDS Biotechnology Corporation (NASDAQ) VS. Canton Strategic Holdings Inc. (NASDAQ) • 15-METRIC TALLY: PDSB 2
— CNTN 3
■ METRIC PARITY
LAST: $1.44 (-7.10%) • MKT CAP: $162.8M
valuation
—
LAST: $1.95 (-4.88%) • MKT CAP: $163.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDSB VS. CNTN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDSB | CNTN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -4.10% | -30.90 | CNTN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.05% | -9.87% | -7.18 | CNTN | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | PDSB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.4 | 46.9 | +12.52 | PDSB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $162.8M | $163.3M | -$588.4K | CNTN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDSB REV | CNTN REV | PDSB GROSS % | CNTN GROSS % | PDSB FCF | CNTN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$27.8M | -$16.1M |
| FY 2024 | $0 | $0 | — | — | -$35.1M | -$10.9M |
| FY 2023 | $0 | $0 | — | — | -$33.6M | -$7.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDSB // BETA —
CNTN // BETA —